Maravai LifeSciences Holdings, Inc. (MRVI) saw its stock price soar 10.66% during intraday trading on Friday, continuing a positive momentum from the pre-market session.
The significant upward movement follows an analyst action from Wells Fargo, which raised its price target on the company to $5.5 from $4.5. Such an increase typically signals improved confidence in the company's future financial performance and growth prospects, often prompting positive investor sentiment and buying activity.